Qube Research & Technologies (QRT) Portfolio holdings
AUM
$72B
1-Year Return
7.86%
This Quarter Return
+5.05%
1 Year Return
+7.86%
3 Year Return
+23.62%
5 Year Return
+38.38%
10 Year Return
–
AUM
$72B
AUM Growth
+$7.58B
(+12%)
Cap. Flow
+$2.92B
Cap. Flow
% of AUM
4.06%
Top 10 Holdings %
Top 10 Hldgs %
9.39%
Holding
3,349
New
570
Increased
1,114
Reduced
905
Closed
559
Top Buys
| 1 |
Apple
AAPL
|
+$492M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$471M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$451M |
| 4 |
Uber
UBER
|
+$426M |
| 5 |
GE Vernova
GEV
|
+$358M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
+$806M |
| 2 |
Broadcom
AVGO
|
+$786M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$587M |
| 4 |
Microsoft
MSFT
|
+$554M |
| 5 |
Applied Materials
AMAT
|
+$467M |
Sector Composition
| 1 | Technology | 18.26% |
| 2 | Financials | 14.26% |
| 3 | Industrials | 14.07% |
| 4 | Healthcare | 13.67% |
| 5 | Consumer Discretionary | 12.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1726
RB Global
RBA
$21.7B
| $1.26M | ﹤0.01% |
+11,850
| New | +$1.26M |
|
1727
Terns Pharmaceuticals
TERN
$633M
| $1.26M | ﹤0.01% |
336,665
-358,494
| -52% | -$1.34M |
|
1728
Neuropace
NPCE
$326M
| $1.25M | ﹤0.01% |
112,637
+48,175
| +75% | +$537K |
|
1729
First Trust Dorsey Wright Focus 5 ETF
FV
$3.73B
| $1.25M | ﹤0.01% |
21,142
+2,976
| +16% | +$176K |
|
1730
Real Brokerage
REAX
$1.04B
| $1.25M | ﹤0.01% |
277,013
+235,507
| +567% | +$1.06M |
|
1731
Stoneridge
SRI
$228M
| $1.24M | ﹤0.01% |
175,427
+6,619
| +4% | +$46.6K |
|
1732
Vanguard Financials ETF
VFH
$12.9B
| $1.22M | ﹤0.01% |
9,587
+9,073
| +1,765% | +$1.15M |
|
1733
Leidos
LDOS
$23.6B
| $1.22M | ﹤0.01% |
7,715
-368,540
| -98% | -$58.1M |
|
1734
Velocity Financial
VEL
$720M
| $1.21M | ﹤0.01% |
65,266
+18,347
| +39% | +$340K |
|
1735
Sixth Street Specialty
TSLX
$2.32B
| $1.21M | ﹤0.01% |
50,774
-168,294
| -77% | -$4.01M |
|
|
NIU
1736
Niu Technologies
NIU
$316M
| $1.21M | ﹤0.01% |
+359,312
| New | +$1.21M |
|
|
SRTA
1737
Strata Critical Medical, Inc. Class A Common Stock
SRTA
$351M
| $1.2M | ﹤0.01% |
298,624
+150,711
| +102% | +$607K |
|
1738
Avantis International Small Cap Value ETF
AVDV
$12.1B
| $1.2M | ﹤0.01% |
15,144
+9,069
| +149% | +$719K |
|
1739
Verastem
VSTM
$598M
| $1.17M | ﹤0.01% |
+282,228
| New | +$1.17M |
|
1740
Madrigal Pharmaceuticals
MDGL
$9.63B
| $1.16M | ﹤0.01% |
+3,844
| New | +$1.16M |
|
1741
iShares Russell 1000 ETF
IWB
$44.5B
| $1.16M | ﹤0.01% |
3,418
+535
| +19% | +$182K |
|
1742
Limoneira
LMNR
$275M
| $1.16M | ﹤0.01% |
74,124
+62,080
| +515% | +$972K |
|
1743
Cohen & Steers
CNS
$3.65B
| $1.16M | ﹤0.01% |
+15,377
| New | +$1.16M |
|
1744
Kornit Digital
KRNT
$647M
| $1.15M | ﹤0.01% |
57,964
-19,798
| -25% | -$394K |
|
1745
FTAI Infrastructure
FIP
$518M
| $1.15M | ﹤0.01% |
185,584
-249,503
| -57% | -$1.54M |
|
1746
Vanguard Total Stock Market ETF
VTI
$536B
| $1.14M | ﹤0.01% |
3,763
-23,808
| -86% | -$7.24M |
|
1747
Rogers Communications
RCI
$19.3B
| $1.14M | ﹤0.01% |
38,398
-148,379
| -79% | -$4.4M |
|
1748
Arbutus Biopharma
ABUS
$855M
| $1.14M | ﹤0.01% |
368,030
+72,689
| +25% | +$225K |
|
1749
iShares Global REIT ETF
REET
$3.92B
| $1.14M | ﹤0.01% |
46,006
+13,410
| +41% | +$331K |
|
1750
SandRidge Energy
SD
$420M
| $1.14M | ﹤0.01% |
104,936
+20,967
| +25% | +$227K |
|